Related Experiment Video
Updated: Jun 2, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Atrial fibrillation ablation: a cost or an investment?
Josef Kautzner1, Veronika Bulkova, Gerhard Hindricks
1Department of Cardiology, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague 4, Czech Republic. josef.kautzner@medicon.cz
Insights
Catheter ablation (CA) is cost-effective for symptomatic atrial fibrillation (AF) patients unresponsive to drugs, particularly those with paroxysmal AF and long-term quality of life benefits. Further research is needed for persistent AF cases.
Area of Science:
- Cardiology
- Health Economics
Background:
- Catheter ablation (CA) is a therapeutic option for symptomatic atrial fibrillation (AF) unresponsive to antiarrhythmic drugs (AAD).
- Economic analysis of CA is complex due to various factors including AF type, patient characteristics, ablation techniques, and center experience.
Purpose of the Study:
- To evaluate the cost-effectiveness of catheter ablation for atrial fibrillation.
- To identify patient subgroups and conditions where CA is most economically viable.
Main Methods:
- Review of existing literature and economic analyses concerning catheter ablation for atrial fibrillation.
- Consideration of confounding factors influencing cost-effectiveness, such as AF patterns, patient profiles, and procedural variations.
Main Results:
- CA is currently cost-effective primarily for paroxysmal AF patients refractory to AADs, especially with >5 years of sustained benefit and low complication rates.
- Cost-effectiveness data for persistent/long-term persistent AF or AF with heart failure require further investigation.
- CA is unlikely to be cost-effective for patients with preserved quality of life or those whose quality of life is unlikely to improve significantly due to other health issues.
Conclusions:
- Catheter ablation demonstrates cost-effectiveness in specific atrial fibrillation patient populations, notably paroxysmal AF refractory to AADs.
- Careful patient selection is crucial for optimizing the economic benefits of atrial fibrillation ablation.
- Further research is warranted to establish the cost-effectiveness of CA in more complex AF presentations.
Abstract:
In the last decade, catheter ablation (CA) became a viable therapeutic approach for symptomatic patients with atrial fibrillation (AF) non-responsive to antiarrhythmic drugs (AAD). The economic analysis of CA is complex due to the presence of several confounding factors, such as the pattern of AF (paroxysmal AF, persistent or long-term persistent AF), the patient population (age, presence/absence of underlying structural heart disease, comorbidities, etc.), the different techniques for ablation (with impact on complexity and cost of the procedure, as well as on efficacy and safety), and the learning curve and experience of an individual centre (with impact on efficacy and cost effectiveness). At present, CA appears to be cost effective mainly in patients with paroxysmal AF who are refractory to AADs, especially if the success of the procedure and, thus, the benefit in quality of life remains >5 years, with a low complication rate. More data are needed on cost effectiveness of CA of persistent and long-term persistent AF or of AF associated with heart failure. Atrial fibrillation ablation is unlikely to be cost effective for patients who have preserved quality of life despite their AF or for patients whose quality of life is not expected to improve substantially despite elimination of AF (e.g. patients with poor quality of life mainly due to other health problems). These observations may help in the selection of candidates for AF ablation.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy V: Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias V: Evaluating Dysrhythmias

